Cargando…

Expression and Function of CD44 in Epithelial Ovarian Carcinoma

CD44, a cell surface glycoprotein, has been increasingly implicated in the pathogenesis and progression of epithelial ovarian cancer, the deadliest gynecologic malignancy in women. Here, we review recent reports on the expression and function of CD44 in epithelial ovarian carcinoma. Further function...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sacks, Joelle D., Barbolina, Maria V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693269/ https://www.ncbi.nlm.nih.gov/pubmed/26569327 http://dx.doi.org/10.3390/biom5043051

Ejemplares similares

Versican regulates metastasis of epithelial ovarian carcinoma cells and spheroids
por: Desjardins, Mark, et al.
Publicado: (2014)

Regulation of DNA damage repair and lipid uptake by CX(3)CR1 in epithelial ovarian carcinoma
por: Xie, Jia, et al.
Publicado: (2018)

Molecular Mechanisms Regulating Organ-Specific Metastases in Epithelial Ovarian Carcinoma
por: Barbolina, Maria V.
Publicado: (2018)

Chemokine Receptors in Epithelial Ovarian Cancer
por: Muralidhar, Goda G., et al.
Publicado: (2013)

The miR-200 Family: Versatile Players in Epithelial Ovarian Cancer
por: Muralidhar, Goda G., et al.
Publicado: (2015)

Expression of CD44v6 and Its Association with Prognosis in Epithelial Ovarian Carcinomas
por: Zhou, Dang-xia, et al.
Publicado: (2012)

Targeting Microtubule-Associated Protein Tau in Chemotherapy-Resistant Models of High-Grade Serous Ovarian Carcinoma
por: Barbolina, Maria V.
Publicado: (2022)

Emergent Role of the Fractalkine Axis in Dissemination of Peritoneal Metastasis from Epithelial Ovarian Carcinoma
por: Main, Hilal Gurler, et al.
Publicado: (2016)

Expression and Significance of CD44, CD47 and c-met in Ovarian Clear Cell Carcinoma
por: Wang, Huimin, et al.
Publicado: (2015)

MMP-14 and CD44 in Epithelial-to-Mesenchymal Transition (EMT) in ovarian cancer
por: Vos, Maria Caroline, et al.
Publicado: (2016)

Examination of the Fractalkine and Fractalkine Receptor Expression in Fallopian Adenocarcinoma Reveals Differences When Compared to Ovarian Carcinoma
por: Gurler, Hilal, et al.
Publicado: (2015)

High Expression of Lewis y Antigen and CD44 Is Correlated with Resistance to Chemotherapy in Epithelial Ovarian Cancers
por: Hu, Zhenhua, et al.
Publicado: (2013)

Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment
por: Barbolina, Maria V., et al.
Publicado: (2011)

Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis
por: Ween, Miranda P., et al.
Publicado: (2011)

The role of CD44 in epithelial–mesenchymal transition and cancer development
por: Xu, Hanxiao, et al.
Publicado: (2015)

CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients
por: Li, Zhonghu, et al.
Publicado: (2014)

Fractalkine receptor is expressed in mature ovarian teratomas and required for epidermal lineage differentiation
por: Rooper, Lisa, et al.
Publicado: (2013)

Correlation of PKM2 and CD44 Protein Expression with Poor Prognosis in Platinum-Treated Epithelial Ovarian Cancer: A Retrospective Study
por: Papadaki, Chara, et al.
Publicado: (2020)

Human epithelial ovarian cancer cells expressing CD105, CD44 and CD106 surface markers exhibit increased invasive capacity and drug resistance
por: Zhang, Jin, et al.
Publicado: (2019)

Correlation of CD44v6 expression with ovarian cancer progression and recurrence
por: Shi, Jun, et al.
Publicado: (2013)

Inhibitory effects of metformin at low concentration on epithelial–mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells
por: Zhang, Rongrong, et al.
Publicado: (2015)

Structure, function and role of CD44 in neoplasia
por: Mishra, Mithilesh N, et al.
Publicado: (2019)

CD44s and CD44v6 Expression in Head and Neck Epithelia
por: Mack, Brigitte, et al.
Publicado: (2008)

Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells
por: Montero-Montero, Lucía, et al.
Publicado: (2020)

CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer
por: Tjhay, Francisca, et al.
Publicado: (2015)

The liberation of CD44
por: Cichy, Joanna, et al.
Publicado: (2003)

CD44 in rheumatoid arthritis
por: Naor, David, et al.
Publicado: (2003)

Understanding the role of CD44V6 in ovarian cancer
por: Zhang, Hui-Feng, et al.
Publicado: (2017)

Characterization of CD44 variant expression in head and neck squamous cell carcinomas
por: Spiegelberg, D., et al.
Publicado: (2013)

CD44 Expression in Oro-Pharyngeal Carcinoma Tissues and Cell Lines
por: Rajarajan, Abirami, et al.
Publicado: (2012)

A Study of CD44 Positive Cancer Cells in Epithelial Ovarian Cancer and their Correlation with P53 And Ki67
por: Kar, Ketaki, et al.
Publicado: (2021)

Retraction Note: Correlation of CD44v6 expression with ovarian cancer progression and recurrence
por: Shi, Jun, et al.
Publicado: (2020)

Recent perspectives of epithelial ovarian carcinoma
por: Zhang, Xiao-Ying, et al.
Publicado: (2016)

Three-Dimensional Collagen Type I Matrix Up-Regulates Nuclear Isoforms of the Microtubule Associated Protein Tau Implicated in Resistance to Paclitaxel Therapy in Ovarian Carcinoma
por: Gurler, Hilal, et al.
Publicado: (2015)

Correlation of Soluble CD44 Expression in Saliva and CD44 Protein in Oral Leukoplakia Tissues
por: Čēma, Ingrīda, et al.
Publicado: (2021)

Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis
por: Han, Zhengquan, et al.
Publicado: (2015)

CD44 Plays a Functional Role in Helicobacter pylori-induced Epithelial Cell Proliferation
por: Bertaux-Skeirik, Nina, et al.
Publicado: (2015)

The Expression and Functional Significance of Vascular Endothelial-Cadherin, CD44, and Vimentin in Oral Squamous Cell Carcinoma
por: Irani, Soussan, et al.
Publicado: (2018)

Clinicopathological significance of fascin and CD44v6 expression in endometrioid carcinoma
por: Gun, Banu Dogan, et al.
Publicado: (2012)

Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression
por: Rani, Bhavna, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0l6b0ov250kp5jdarkmtsojfuv